In fact their h2 expense ratio was excellent at 21.6% est, while loss ratio for h2 was 71.9% est versus h1 70.7%, and h2 15 of 71. So up a bit only. On reflection that diff works out at about $36m off the underwriting result.
- Forums
- ASX - By Stock
- SUN
- SUN - Time to Buy??
SUN - Time to Buy??, page-89
-
-
- There are more pages in this discussion • 46 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SUN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.95 |
Change
-0.025(0.15%) |
Mkt cap ! $21.45B |
Open | High | Low | Value | Volume |
$17.04 | $17.12 | $16.83 | $16.86M | 995.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 6030 | $16.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.95 | 1687 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
37 | 7028 | 16.940 |
25 | 4974 | 16.930 |
16 | 3812 | 16.920 |
15 | 12304 | 16.910 |
9 | 11842 | 16.900 |
Price($) | Vol. | No. |
---|---|---|
16.950 | 1716 | 18 |
16.960 | 4246 | 23 |
16.970 | 4848 | 12 |
16.980 | 6341 | 8 |
16.990 | 4445 | 8 |
Last trade - 15.46pm 15/07/2024 (20 minute delay) ? |
Featured News
SUN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online